A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2012.11.354
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2013
Authors
Publisher
Elsevier BV